Eton Pharmaceuticals, Inc. ETON Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s operating lease liabilities?
- Eton Pharmaceuticals, Inc. (ETON) reported operating lease liabilities of $440K in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s operating lease liabilities changed year-over-year?
- Eton Pharmaceuticals, Inc.'s operating lease liabilities increased by 405.7% year-over-year, from $87K to $440K.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s operating lease liabilities has grown at a 36.0% compound annual growth rate (CAGR), from $99K to $460K.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.